Poly (ADP-Ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma

Katalin Komjáti, Valerie C. Besson, Csaba Szabo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Poly (ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding protein that is primarily activated by nicks in the DNA molecule. It regulates the activity of various enzymes - including itself- that are involved in the control of DNA metabolism. Upon binding to DNA breaks, activated PARP cleaves NAD+ into nicotinamide and ADP-ribose and polymerizes the latter on nuclear acceptor proteins including histones, transcription factors and PARP itself. Poly(ADP-ribosylation) contributes to DNA repair and to the maintenance of genomic stability. Evidence obtained with pharmacological PARP inhibitors of various structural classes, as well as animals lacking the PARP-1 enzyme indicate that PARP plays an important role in cerebral ischemia /reperfusion, stroke and neurotrauma. Overactivation of PARP consumes NAD+ and ATP culminating in cell dysfunction and necrosis. PARP activation can also act as a signal that initiates cell death programs, for instance through AIF (apoptosis inducing factor) translocation. PARP has also been shown to associate with and regulate the function of several transcription factors. Of special interest is the enhancement by PARP of NF-κB-mediated transcription, which plays a central role in the expression of inflammatory cytokines, chemokines, adhesion molecules and inflammatory mediators. Via this mechanism, PARP is involved in the up-regulation of numerous pro-inflammatory genes that play a pathogenetic role in the later stage of stroke and neurotrauma. Here we review the roles of PARP in DNA damage signaling and cell death, and summarize the pathogenetic role of PARP in stroke and neurotrauma.

Original languageEnglish (US)
Pages (from-to)179-194
Number of pages16
JournalCurrent Drug Targets: CNS and Neurological Disorders
Volume4
Issue number2
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Stroke
NAD
Cell Death
Transcription Factors
Apoptosis Inducing Factor
Adenosine Diphosphate Ribose
Single-Stranded DNA Breaks
DNA Breaks
Genomic Instability
DNA-Binding Proteins
Enzymes
Nuclear Proteins
Brain Ischemia
Chemokines
DNA Repair
Histones
Adenosine Diphosphate
DNA Damage
Reperfusion
Necrosis

Keywords

  • Apoptosis
  • CNS
  • Inflammation
  • Ischemia
  • Necrosis
  • Poly(ADP-ribose) polymerase
  • Spinal cord injury
  • Stroke

ASJC Scopus subject areas

  • Pharmacology
  • Neuroscience(all)

Cite this

Poly (ADP-Ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma. / Komjáti, Katalin; Besson, Valerie C.; Szabo, Csaba.

In: Current Drug Targets: CNS and Neurological Disorders, Vol. 4, No. 2, 04.2005, p. 179-194.

Research output: Contribution to journalArticle

@article{28d52ecdbbf44b13a07620acded82990,
title = "Poly (ADP-Ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma",
abstract = "Poly (ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding protein that is primarily activated by nicks in the DNA molecule. It regulates the activity of various enzymes - including itself- that are involved in the control of DNA metabolism. Upon binding to DNA breaks, activated PARP cleaves NAD+ into nicotinamide and ADP-ribose and polymerizes the latter on nuclear acceptor proteins including histones, transcription factors and PARP itself. Poly(ADP-ribosylation) contributes to DNA repair and to the maintenance of genomic stability. Evidence obtained with pharmacological PARP inhibitors of various structural classes, as well as animals lacking the PARP-1 enzyme indicate that PARP plays an important role in cerebral ischemia /reperfusion, stroke and neurotrauma. Overactivation of PARP consumes NAD+ and ATP culminating in cell dysfunction and necrosis. PARP activation can also act as a signal that initiates cell death programs, for instance through AIF (apoptosis inducing factor) translocation. PARP has also been shown to associate with and regulate the function of several transcription factors. Of special interest is the enhancement by PARP of NF-κB-mediated transcription, which plays a central role in the expression of inflammatory cytokines, chemokines, adhesion molecules and inflammatory mediators. Via this mechanism, PARP is involved in the up-regulation of numerous pro-inflammatory genes that play a pathogenetic role in the later stage of stroke and neurotrauma. Here we review the roles of PARP in DNA damage signaling and cell death, and summarize the pathogenetic role of PARP in stroke and neurotrauma.",
keywords = "Apoptosis, CNS, Inflammation, Ischemia, Necrosis, Poly(ADP-ribose) polymerase, Spinal cord injury, Stroke",
author = "Katalin Komj{\'a}ti and Besson, {Valerie C.} and Csaba Szabo",
year = "2005",
month = "4",
doi = "10.2174/1568007053544138",
language = "English (US)",
volume = "4",
pages = "179--194",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Poly (ADP-Ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma

AU - Komjáti, Katalin

AU - Besson, Valerie C.

AU - Szabo, Csaba

PY - 2005/4

Y1 - 2005/4

N2 - Poly (ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding protein that is primarily activated by nicks in the DNA molecule. It regulates the activity of various enzymes - including itself- that are involved in the control of DNA metabolism. Upon binding to DNA breaks, activated PARP cleaves NAD+ into nicotinamide and ADP-ribose and polymerizes the latter on nuclear acceptor proteins including histones, transcription factors and PARP itself. Poly(ADP-ribosylation) contributes to DNA repair and to the maintenance of genomic stability. Evidence obtained with pharmacological PARP inhibitors of various structural classes, as well as animals lacking the PARP-1 enzyme indicate that PARP plays an important role in cerebral ischemia /reperfusion, stroke and neurotrauma. Overactivation of PARP consumes NAD+ and ATP culminating in cell dysfunction and necrosis. PARP activation can also act as a signal that initiates cell death programs, for instance through AIF (apoptosis inducing factor) translocation. PARP has also been shown to associate with and regulate the function of several transcription factors. Of special interest is the enhancement by PARP of NF-κB-mediated transcription, which plays a central role in the expression of inflammatory cytokines, chemokines, adhesion molecules and inflammatory mediators. Via this mechanism, PARP is involved in the up-regulation of numerous pro-inflammatory genes that play a pathogenetic role in the later stage of stroke and neurotrauma. Here we review the roles of PARP in DNA damage signaling and cell death, and summarize the pathogenetic role of PARP in stroke and neurotrauma.

AB - Poly (ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding protein that is primarily activated by nicks in the DNA molecule. It regulates the activity of various enzymes - including itself- that are involved in the control of DNA metabolism. Upon binding to DNA breaks, activated PARP cleaves NAD+ into nicotinamide and ADP-ribose and polymerizes the latter on nuclear acceptor proteins including histones, transcription factors and PARP itself. Poly(ADP-ribosylation) contributes to DNA repair and to the maintenance of genomic stability. Evidence obtained with pharmacological PARP inhibitors of various structural classes, as well as animals lacking the PARP-1 enzyme indicate that PARP plays an important role in cerebral ischemia /reperfusion, stroke and neurotrauma. Overactivation of PARP consumes NAD+ and ATP culminating in cell dysfunction and necrosis. PARP activation can also act as a signal that initiates cell death programs, for instance through AIF (apoptosis inducing factor) translocation. PARP has also been shown to associate with and regulate the function of several transcription factors. Of special interest is the enhancement by PARP of NF-κB-mediated transcription, which plays a central role in the expression of inflammatory cytokines, chemokines, adhesion molecules and inflammatory mediators. Via this mechanism, PARP is involved in the up-regulation of numerous pro-inflammatory genes that play a pathogenetic role in the later stage of stroke and neurotrauma. Here we review the roles of PARP in DNA damage signaling and cell death, and summarize the pathogenetic role of PARP in stroke and neurotrauma.

KW - Apoptosis

KW - CNS

KW - Inflammation

KW - Ischemia

KW - Necrosis

KW - Poly(ADP-ribose) polymerase

KW - Spinal cord injury

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=18044388712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044388712&partnerID=8YFLogxK

U2 - 10.2174/1568007053544138

DO - 10.2174/1568007053544138

M3 - Article

VL - 4

SP - 179

EP - 194

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 2

ER -